Loading chat...
NY A09250
Bill
Status
2/9/2022
Primary Sponsor
John McDonald
Click for details
AI Summary
-
Amends the Insurance Law and Public Health Law to prohibit step therapy protocols from applying to medically necessary prescription drugs in seven therapeutic classes: dermatologic, hematology, ophthalmologic, rheumatic, gastrointestinal, neurology, and oncology.
-
Requires utilization review agents to ensure step therapy protocols exclude non-formulary drugs within the specified therapeutic classes.
-
Applies the restriction to both insurance carriers regulated under Insurance Law Section 4902 and utilization review agents under Public Health Law Section 4902.
-
Takes effect immediately upon enactment.
Legislative Description
Ensures that step therapy shall not apply to medically necessary prescription drugs in the dermatologic, hematology, ophthalmologic, rheumatic, gastrointestinal, neurology, and oncology therapeutic classes, including non-formulary drugs.
Last Action
referred to insurance
2/9/2022